BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr
X-WR-CALDESC:Évènements pour Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221010
DTEND;VALUE=DATE:20221027
DTSTAMP:20260410T120829
CREATED:20211029T154749Z
LAST-MODIFIED:20221028T143428Z
UID:140646-1665360000-1666828799@www.bordeaux-neurocampus.fr
SUMMARY:Cajal course - "Brain Organoids"
DESCRIPTION:Bordeaux School of Neuroscience \nMore details\nhttp://www.bordeaux-school-of-neuroscience.eu/trainings/cajal/cajal-2022/bo-2022/ \n
URL:https://www.bordeaux-neurocampus.fr/event/cajal-course-brain-organoids/
CATEGORIES:A la une,Cajal Lectures,Pour les scientifiques
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20221010T140000
DTEND;TZID=Europe/Paris:20221010T140000
DTSTAMP:20260410T120829
CREATED:20220921T081112Z
LAST-MODIFIED:20220921T122648Z
UID:151042-1665410400-1665410400@www.bordeaux-neurocampus.fr
SUMMARY:Seminar - Banafshe Larijani
DESCRIPTION:Venue: Centre Broca \n\nBanafshe Larijani\nBanafshe Larijani\nDirector of The Centre for Therapeutic Innovation- University of Bath\, United Kingdom \nInvited by Marc Landry (IMN) \nTitle\nQuantitative Immune Surveyance: a path to precision therapeutics \nAbstract\nI will be presenting how we have employed\, in an interdisciplinary arena\, quantitative molecular biology to investigate in situ molecular mechanisms in the PI 3Kinase pathway. These studies led to applying our molecular imaging methods in clinical environments. We have addressed pertinent questions regarding the exploitation of functional proteomics\, as opposed to expressional proteomics in diagnostics and prognostics of various types of cancers. The implementation of this type of quantitative imaging\, in deciphering mechanisms involved in signalling pathways in pain will be discussed. \nBiography\nBanafshé Larijani is the Director of the Centre for Therapeutics Innovation (CTI) at the University of Bath. CTI is an Internationally faced research and innovation Centre with the mission to transform innovation\, arising from cross-disciplinary research to quantitative diagnostics & medicines-design\, leading to precision medicine. \nHer laboratory\, Cell Biophysics\, since 2002 in the UK and Spain has been the core of an international network that spans from the physical sciences\, engineering\, life sciences to translational science. \nProfessor Larijani’s laboratory is a cutting-edge cross-disciplinary platform\, that has drawn upon the physical sciences to develop novel avenues for investigation of biological processes in signalling pathways. Her laboratory has led to paving a unique path by investigating the role of phosphoinositides and their metabolites\, both as second messengers and as modulators of membrane morphology\, exploiting both marine and mammalian models. The outcomes of her fundamental research\, involving the application of quantitative imaging (FRET-FLIM) for investigating molecular mechanisms and dynamics of phosphoinositide-modifying and phosphoinositide-dependant enzymes have resulted in their application to various clinical objectives. \nWhile in the Basque Country (2014-2018)\, Spain\, the cancer diagnostic/prognostic company\, she co-founded and directed (until 2018)\, FASTBASE SOLUTIONS S.L.\, won European and French Awards for best “predictive cancer diagnostic test”. \nSelected references\n\nBanafshé Larijani and James Miles (2022) Quantification of protein-protein interactions and activation dynamics: A new path to predictive biomarkers Biophysical Chemistry doi.org/10.1016/j.bpc.2022.106768\nLissete Sánchez-Magraner**\, James Miles**\, Claire L. Baker\, Christopher J Applebee\, Dae-Jin Lee\, Somaia Elsheikh\, Shaimaa Lashin\, Katriona Withers\, Andrew G. Watts \, Richard Parry \, Christine Edmead \, Jose Ignacio Lopez \, Raj Mehta\, Antoine Italiano \, Stephen G Ward\, Peter J. Parker\, Banafshé Larijani (2020) High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment. Cancer Research Doi: 10.1158/0008-5472.CAN-20-1117\nGloria de las Heras-Martínez*\, Véronique Calleja*\, Remy Bailly\, Jean Dessolin\, Banafshé Larijani**\, Jose Requejo-Isidro** (2019) A Complex Interplay of Anionic Phospholipid Binding Regulates 3′-Phosphoinositide-Dependent-Kinase-1 Homodimer Activation. Scientific Reports. doi: 10.1038/s41598-019-50742-8\nJames Miles\, Christopher J. Applebee\, Pierre Leboucher\, Sonia Lopez-Fernandez\, Dae-Jin Lee\, Rosa Guarch\, Stephen Ward\, Peter J. Parker\, Jose I. López\, Banafshé Larijani (2017) Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma. BBACLI 161. doi:10.1016/j.bbacli.2017.10.002\nGloria de las Heras-Martınez\, Josu Andrieu\, Banafshe Larijani and Jose Requejo-Isidro (2017) Quantifying intracellular equilibrium dissociation constants using single-channel time-resolved FRET Journal of Biophotonics DOI 10.1002/jbio.20160027\nSelvaraju Veeriah\, Pierre Leboucher\, Julien de Naurois\, Nirmal Jethwa\, Emma Nye\, Tamara Bunting\, Richard Stone\, Véronique Calleja\, Gordon Stamp\, Stefanie Jeffrey\, Peter J Parker\, Banafshé Larijani (2014) Akt/PKB activation in human primary breast carcinoma is a poor prognostic marker: determined by high throughput coincidence amplified-FRET. Cancer Research- 15;74(18):4983-95\n\n  \n
URL:https://www.bordeaux-neurocampus.fr/event/seminar-banafshe-larijani/
CATEGORIES:A la une,Pour les scientifiques,Séminaire Impromptu
END:VEVENT
END:VCALENDAR